Press Releases about Agenus Inc
Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
September 13, 2024
From Agenus Inc.
Via Business Wire
Agenus to Participate in September Investor Conferences
September 03, 2024
From Agenus Inc.
Via Business Wire
From Agenus Inc.
Via Business Wire
From Agenus Inc.
Via Business Wire
From Agenus Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|